IRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo, SS 113, C. da Casazza, Messina, 98124, Italy.
LUNEX, Differdange, Luxembourg.
J Neuroeng Rehabil. 2024 Sep 13;21(1):159. doi: 10.1186/s12984-024-01449-z.
Neurological disorders, such as Parkinson's disease (PD), multiple sclerosis (MS), cerebral palsy (CP) and stroke are well-known causes of gait and balance alterations. Innovative devices (i.e., robotics) are often used to promote motor recovery. As an alternative, anti-gravity treadmills, which were developed by NASA, allow early mobilization, walking with less effort to reduce gait energy costs and fatigue. A systematic search, according to PRISMA guidelines, was conducted for all peer-reviewed articles published from January 2010 through September 2023, using the following databases: PubMed, Scopus, PEDro and IEEE Xplore. After an accurate screening, we selected only 16 articles (e.g., 5 RCTs, 2 clinical trials, 7 pilot studies, 1 prospective study and 1 exploratory study). The evidence collected in this systematic review reported promising results in the field of anti-gravity technology for neurological patients, in terms of improvement in gait and balance outcomes. However, we are not able to provide any clinical recommendation about the dose and parameters of anti-gravity treadmill training, because of the lack of robust high-quality RCT studies and large samples. Registration number CRD42023459665.
神经系统疾病，如帕金森病（PD）、多发性硬化症（MS）、脑瘫（CP）和中风，是导致步态和平衡改变的已知原因。创新设备（如机器人）常被用于促进运动康复。作为替代方案，美国宇航局（NASA）开发的减重跑步机允许早期活动，减少行走时的体力消耗，从而降低步态能量消耗和疲劳。根据 PRISMA 指南，我们对 2010 年 1 月至 2023 年 9 月发表的所有同行评审文章进行了系统搜索，使用了以下数据库：PubMed、Scopus、PEDro 和 IEEE Xplore。经过准确筛选，我们仅选择了 16 篇文章（例如，5 项 RCT、2 项临床试验、7 项试点研究、1 项前瞻性研究和 1 项探索性研究）。本系统评价中收集的证据表明，在神经患者的减重技术领域，在改善步态和平衡结果方面具有前景。然而，由于缺乏高质量的 RCT 研究和大样本，我们无法就减重跑步机训练的剂量和参数提供任何临床建议。注册号 CRD42023459665。
